Determination of binding constant of DNA-binding drug to target DNA by surface plasmon resonance biosensor technology.

Lin LP, Huang LS, Lin CW, Lee CK, Chen JL, Hsu SM, Lin S. Determination of binding constant of DNA-binding drug to target DNA by surface plasmon resonance biosensor technology. Curr Drug Targets Immune Endocr Metabol Disord. 2005 Mar; 5(1):61-72.

View in: PubMed

subject areas

Animals
Binding Sites
DNA
Drug Delivery Systems
Humans
Pharmaceutical Preparations
Surface Plasmon Resonance

authors with profiles

Chii-Dean Lin

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support